Abstract:5514 Background: Accurate means to refine the prognosis of local advanced nasopharyngeal carcinoma (NPC) will improve the selection of patients for tailored therapy. Here, we addressed this issue by developing a mathematical algorithm, Support Vector Machine (SVM), by integrating pathological multibiomarkers. Methods: Ninety-seven local advanced NPC patients (stage III and IVa) in a randomized controlled trial (RCT), consisting of 48 cases serving as the training set and 49 cases as testing set of SVM models, with a 5-year follow-up were selected and studied. We designed 3 SVM models by selecting the variables from 38 tissue molecular biomarkers and 3 EBV related serological biomarkers. Results: The SVM1 displayed highly prognostic sensitivity (sensitivity, specificity, positive predictive value, negative predictive value, and overall accuracy were 88.0%, 81.9%, 62.9%, 95.2% and 83.5%, respectively) by integrating 7 molecular biomarkers (Aurora-A, Beclin 1, Ki-67, N-cadherin, nm23-H1, P27, and TIMP 2). The SVM2 model showed highly prognostic specificity (sensitivity, specificity, positive predictive value, negative predictive value, and overall accuracy were 84.0%, 94.5%, 84.0%, 94.4% and 91.8%, respectively) by grouping 12 molecular biomarkers (nm23-H1, Pontin, cyclin D1, N-Cadherin, 14-3-3s, Ki-67, Aurora-A, Bcl-2, Beclin 1, MMP 2, EZH2 and TIMP 2) and 3 EBV related serological biomarkers (EA-IgA, VCA-IgA and AER). The SVM3 model, constructed by combination SVM1 with SVM2, displayed a high prognostic capacity (sensitivity, specificity, positive predictive value, negative predictive value, and overall accuracy were 88.0%, 90.3%, 75.9%, 95.6% and 89.7%, respectively). Moreover, Cox multivariate regression analysis confirmed that these 3 SVM models were each the significant independent prognostic model (SVM1, HR: 70.745, P = 0.000; SVM2, HR: 145.080, P = 0.000; SVM3, HR: 113.594, P = 0.000) for overall survival in testing set and overall patients. Conclusions: Our SVM prognostic models designed in the RCT displayed strong power in refining patient prognosis for local advanced NPC, potentially directing future target therapy against the correlated signaling pathways.

Prognosis-related Molecular Subtyping of Nasopharyngeal Carcinoma

Identification of Prognostic Biomarkers for Response to Radiotherapy by DNA Microarray in Nasopharyngeal Carcinoma Patients

Prognostic Implications of a Molecular Classifier Derived from Whole‐exome Sequencing in Nasopharyngeal Carcinoma

Identification of markers for predicting prognosis and endocrine metabolism in nasopharyngeal carcinoma by miRNA-mRNA network mining and machine learning

An immune-related prognostic model predicts neoplasm-immunity interactions for metastatic nasopharyngeal carcinoma

Molecular Prognostic Prediction For Locally Advanced Nasopharyngeal Carcinoma By Support Vector Machine Integrated Approach

Novel prognostic biomarkers in nasopharyngeal carcinoma unveiled by mega-data bioinformatics analysis

Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics

Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma

Exploration of a Novel Prognostic Risk Signature and Its Effect on the Immune Response in Nasopharyngeal Carcinoma

Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes

Proteomics Profiling Reveals the Molecular Signatures and Potential Therapeutic Targets of Human Nasopharyngeal Carcinoma

Proposal of a Clinical Typing System and Generation of a Prognostic Model in Patients with Nasopharyngeal Carcinoma from Southern China.

Molecular Prognostic Prediction By Support Vector Machine Integrated Approach For Local Advanced Nasopharyngeal Carcinoma.

Gene Expression Profile Changes and Possible Molecular Subtypes in Differentiated-Type Nonkeratinizing Nasopharyngeal Carcinoma

Identification of a five-miRNA signature as a novel potential prognostic biomarker in patients with nasopharyngeal carcinoma

Communication between cancer cell subtypes by exosomes contributes to nasopharyngeal carcinoma metastasis and poor prognosis

A novel proteomic prognostic signature characterizes the immune landscape and predicts nasopharyngeal carcinoma prognosis

Comprehensive analysis of key genes associated with ceRNA networks in nasopharyngeal carcinoma based on bioinformatics analysis

Transcriptional Patterns, Biomarkers and Pathways Characterizing Nasopharyngeal Carcinoma of Southern China

Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responses